APA (7th ed.) Citation

Lin, G., Chi, A., Cai, S., Zhang, Y., Ren, Y., Lu, X., . . . Zhu, Y. (2026). CD36 serves as a potential drug-target to alleviate inflammation in atherosclerosis via leonurine-mediated blockade of its activation pocket. Free Radical Biology & Medicine, 251, 256. https://doi.org/10.1016/j.freeradbiomed.2026.03.077

Chicago Style (17th ed.) Citation

Lin, Ge, et al. "CD36 Serves as a Potential Drug-target to Alleviate Inflammation in Atherosclerosis via Leonurine-mediated Blockade of Its Activation Pocket." Free Radical Biology & Medicine 251 (2026): 256. https://doi.org/10.1016/j.freeradbiomed.2026.03.077.

MLA (9th ed.) Citation

Lin, Ge, et al. "CD36 Serves as a Potential Drug-target to Alleviate Inflammation in Atherosclerosis via Leonurine-mediated Blockade of Its Activation Pocket." Free Radical Biology & Medicine, vol. 251, 2026, p. 256, https://doi.org/10.1016/j.freeradbiomed.2026.03.077.